An FDA advisory panel votes against recommending approval for SonaCare Medical's Sonablate system to treat recurrent prostate cancer.
SonaCare Medical said it will reposition its Sonablate prostate cancer device to treat a more aggressive stage of the disease after an FDA panel last week failed to recommend approval for the device.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1xig7bF
Cap comentari:
Publica un comentari a l'entrada